Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 5.

Journal Article

Rogasch, Julian M. M., Boellaard, Ronald, Pike, Lucy ORCID: 0000-0002-4381-3349, Borchmann, Peter, Johnson, Peter ORCID: 0000-0003-2306-4974, Wolf, Jurgen, Barrington, Sally F. and Kobe, Carsten (2021). Moving the goalposts while scoring-the dilemma posed by new PET technologies. Eur. J. Nucl. Med. Mol. Imaging, 48 (9). S. 2696 - 2711. NEW YORK: SPRINGER. ISSN 1619-7089

Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene ORCID: 0000-0001-7265-7691, Moccia, Alden ORCID: 0000-0001-8816-5464, Salles, Gilles, McKee, Thomas ORCID: 0000-0002-2147-3136, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter ORCID: 0000-0003-2306-4974, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves and Flahault, Antoine (2020). Resources-Stratified Guidelines for Classical Hodgkin Lymphoma. Int. J. Environ. Res. Public Health, 17 (5). BASEL: MDPI. ISSN 1660-4601

Younes, Anas, Sehn, Laurie H., Johnson, Peter ORCID: 0000-0003-2306-4974, Zinzani, Pier Luigi, Hong, Xiaonan, Zhu, Jun, Patti, Caterina, Belada, David ORCID: 0000-0002-4981-6188, Samoilova, Olga, Suh, Cheolwon, Leppae, Sirpa, Rai, Shinya, Turgut, Mehmet, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Cheung, Matthew C., Gurion, Ronit, Yeh, Su-Peng, Lopez-Hernandez, Andres, Duehrsen, Ulrich, Thieblemont, Catherine, Chiattone, Carlos Sergio, Balasubramanian, Sriram, Carey, Jodi, Liu, Grace, Shreeve, S. Martin, Sun, Steven, Zhuang, Sen Hong, Vermeulen, Jessica, Staudt, Louis M., Wilson, Wyndham, Fisher, Richard I., Engert, Andreas, Stadtmauer, Edward A. and Wei, Lee-Jen (2019). Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J. Clin. Oncol., 37 (15). S. 1285 - 1307. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Becker, Ingrid ORCID: 0000-0001-5829-3553, Monsef, Ina, Chadwick, Nicholas, de Sanctis, Vitaliana, Federico, Massimo, Fortpied, Catherine, Gianni, Alessandro M., Henry-Amar, Michel ORCID: 0000-0002-9357-6476, Hoskin, Peter ORCID: 0000-0001-8323-9567, Johnson, Peter ORCID: 0000-0003-2306-4974, Luminari, Stefano ORCID: 0000-0001-8446-2285, Bellei, Monica ORCID: 0000-0001-7846-732X, Pulsoni, Alessandro, Sydes, Matthew R., Valagussa, Pinuccia, Viviani, Simonetta ORCID: 0000-0002-5014-9546, Engert, Andreas and Franklin, Jeremy ORCID: 0000-0003-1536-0925 (2017). Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials. Haematologica, 102 (10). S. 1748 - 1758. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha ORCID: 0000-0003-0663-3004, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter ORCID: 0000-0003-2306-4974, Linton, Kim M., Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Juergen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald (2017). Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol., 4 (11). S. E510 - 14. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

This list was generated on Sat Apr 20 00:41:17 2024 CEST.